Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -171.36% is 15% below its 5-year average of -149.45%, around the middle of its 5-year range (-458.23%–-21.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 17.51% above its 12-month average of -207.72%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -171.36%.
RETURN ON INVESTED CAPITAL (ROIC)
-171.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-207.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-197.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-149.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+17.51%
CURRENT VS 3Y AVG
+13.39%
CURRENT VS 5Y AVG
-14.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 763 covered companies
CURRENT VS SECTOR MEDIAN
-392.83%
vs the sector median at left
Elicio Therapeutics, Inc.
Market Cap
$37.08M
Return on Invested Capital (ROIC)
-171.36%
TTM Avg
-207.72%
3Y Avg
-197.85%
5Y Avg
-149.45%
Market Cap
$37.60M
Return on Invested Capital (ROIC)
-166.02%
TTM Avg
-208.81%
3Y Avg
-185.70%
5Y Avg
-165.34%
Market Cap
$37.71M
Return on Invested Capital (ROIC)
-32.18%
TTM Avg
-103.25%
3Y Avg
-133.41%
5Y Avg
-116.42%
Market Cap
$36.28M
Return on Invested Capital (ROIC)
-22.79%
TTM Avg
-490.24%
3Y Avg
-256.92%
5Y Avg
-224.31%
Market Cap
$35.80M
Return on Invested Capital (ROIC)
-89.44%
TTM Avg
-27.62%
3Y Avg
-11.28%
5Y Avg
-9.71%
Market Cap
$38.47M
Return on Invested Capital (ROIC)
1.99%
TTM Avg
-3.38%
3Y Avg
-2.67%
5Y Avg
-1.50%
Market Cap
$34.76M
Return on Invested Capital (ROIC)
-79.27%
TTM Avg
-43.87%
3Y Avg
-333.47%
5Y Avg
-212.56%
Market Cap
$34.97M
Return on Invested Capital (ROIC)
-164.58%
TTM Avg
-155.30%
3Y Avg
-94.59%
5Y Avg
-73.98%
Market Cap
$34.58M
Return on Invested Capital (ROIC)
-52.61%
TTM Avg
-25.54%
3Y Avg
-42.13%
5Y Avg
-36.31%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $37.08M | -171.36% | -207.72% | -197.85% | -149.45% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.60M | -166.02% | -208.81% | -185.70% | -165.34% |
| Incannex Healthcare Limited (IXHL)vs › | $37.71M | -32.18% | -103.25% | -133.41% | -116.42% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | -22.79% | -490.24% | -256.92% | -224.31% |
| DocGo Inc. (DCGO)vs › | $35.80M | -89.44% | -27.62% | -11.28% | -9.71% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.47M | 1.99% | -3.38% | -2.67% | -1.50% |
| Elutia Inc (ELUT)vs › | $34.76M | -79.27% | -43.87% | -333.47% | -212.56% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | -164.58% | -155.30% | -94.59% | -73.98% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.58M | -52.61% | -25.54% | -42.13% | -36.31% |
| Nephros, Inc. (NEPH)vs › | $40.06M | 12.67% | 5.06% | -12.78% | -16.11% |
ROIC
-171.4%
ROE
-476.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -171.36% |
| 2026-03-31 | -243.08% |
| 2025-12-31 | -212.45% |
| 2025-09-30 | -194.53% |
| 2025-06-30 | -217.19% |
| 2025-03-31 | -271.83% |
| 2024-12-31 | -256.24% |
| 2024-09-30 | -139.27% |
| 2024-06-30 | -458.23% |
| 2024-03-31 | -206.06% |
| 2023-12-31 | -205.54% |
| 2023-09-30 | -165.70% |
| 2023-06-30 | -90.98% |
| 2023-03-31 | -64.48% |
| 2022-12-31 | -196.80% |
| 2022-09-30 | -21.88% |
| 2022-03-31 | -47.11% |
| 2021-12-31 | -29.66% |
| 2021-09-30 | -58.20% |
| 2021-06-30 | -47.19% |
| 2021-03-31 | -312.95% |
| 2020-12-31 | -223.45% |
| 2020-09-30 | -728.64% |
